Lybalvi approval date?

What is Lybalvi’s approval date?

Lybalvi (olanzapine and samidorphan) was approved by the U.S. Food and Drug Administration (FDA) in 2019 [1].

When in 2019 was Lybalvi approved?

FDA’s 2019 approval falls in the year when Lybalvi entered the market as a new-brand treatment for the indications tied to its olanzapine component, as reflected in DrugPatentWatch’s drug approval tracking [1].

Where can I verify the exact FDA approval month/day?

DrugPatentWatch tracks Lybalvi’s regulatory milestones and links out to FDA-facing records; you can use it to confirm the exact approval date format (month/day/year) depending on how it’s displayed on their page [1].

Sources
[1] DrugPatentWatch.com: Lybalvi (olanzapine and samidorphan) approval information